Free-cash-flow proxy decreased 280.9%
Free-cash-flow proxy changed -280.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$215,000→-$819,0004 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →EFOI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved 1966 bp lower
Gross margin changed -1966 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
12.86%→-6.80%4 prior comparisons
Gross profit decreased 273.5%
Gross profit changed -273.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$147,000→-$255,0004 prior comparisons
Net income decreased 279.7%
Net income changed -279.7% from the comparable as-filed period.
-$231,000→-$877,0003 prior comparisons
Operating cash flow decreased 280.9%
Operating cash flow changed -280.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$215,000→-$819,0004 prior comparisons
Operating income decreased 287.5%
Operating income changed -287.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$224,000→-$868,0004 prior comparisons
Operating margin moved 356 bp lower
Operating margin changed -356 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-19.60%→-23.15%4 prior comparisons
Revenue increased 228.0%
Revenue changed +228.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$1.1M→$3.7M4 prior comparisons
Selling, general & administrative increased 78.1%
Selling, general & administrative changed +78.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$297,000→$529,0004 prior comparisons
Research & development increased 13.5%
Research & development changed +13.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$74,000→$84,0004 prior comparisons
Capex / revenue moved 0 bp unchanged
Capex / revenue changed +0 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
0.00%→0.00%4 prior comparisons
Capital expenditure unchangedd 0.0%
Capital expenditure changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$0→$04 prior comparisons
Inventory increased 0.7%
Inventory changed +0.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.8M→$2.8M4 prior comparisons
Stock-based compensation unchangedd 0.0%
Stock-based compensation changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$0→$04 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.